These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27575785)

  • 1. Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension.
    Tiede SL; Wassenberg M; Christ K; Schermuly RT; Seeger W; Grimminger F; Ghofrani HA; Gall H
    Int J Cardiol; 2016 Nov; 223():821-826. PubMed ID: 27575785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.
    Wetzl V; Tiede SL; Faerber L; Weissmann N; Schermuly RT; Ghofrani HA; Gall H
    Lung; 2017 Aug; 195(4):489-496. PubMed ID: 28516393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms?
    Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J
    Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.
    Marc A; Pop C; Sitar-Taut AV; Budisan L; Berindan-Neagoe I; Pop D
    BMC Cardiovasc Disord; 2021 Dec; 21(1):607. PubMed ID: 34930125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix collagen biomarkers levels in patients with chronic thromboembolic pulmonary hypertension.
    Pang W; Zhang Z; Zhang Y; Zhang M; Miao R; Yang Y; Xie W; Wan J; Zhai Z; Wang C
    J Thromb Thrombolysis; 2021 Jul; 52(1):48-58. PubMed ID: 33175289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
    Schäfer M; Ivy DD; Nguyen K; Boncella K; Frank BS; Morgan GJ; Miller-Reed K; Truong U; Colvin K; Yeager ME
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H242-H252. PubMed ID: 34085841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
    Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
    Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases levels in pediatric patients with congenital heart disease: Relationship to cardiac functions.
    Kiliç Z; Uçar B; Özdemir G; Colak Ö; Bal C; Ertuğrul T
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):531-41. PubMed ID: 25233500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
    Todd JL; Vinisko R; Liu Y; Neely ML; Overton R; Flaherty KR; Noth I; Newby LK; Lasky JA; Olman MA; Hesslinger C; Leonard TB; Palmer SM; Belperio JA;
    BMC Pulm Med; 2020 Mar; 20(1):64. PubMed ID: 32171287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    Duits FH; Hernandez-Guillamon M; Montaner J; Goos JD; Montañola A; Wattjes MP; Barkhof F; Scheltens P; Teunissen CE; van der Flier WM
    J Alzheimers Dis; 2015; 48(3):711-20. PubMed ID: 26402072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry.
    Amubieya O; Todd JL; Neely ML; Kaner RJ; Lasky JA; Namen A; Hesslinger C; Palmer SM; Weigt SS; Belperio JA
    PLoS One; 2024; 19(10):e0312044. PubMed ID: 39418259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.
    Gong YL; Xu GM; Huang WD; Chen LB
    J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MMP-9 and TIMP-1 levels on ICU admission are associated with 30-day survival.
    Jordakieva G; Budge-Wolfram RM; Budinsky AC; Nikfardjam M; Delle-Karth G; Girard A; Godnic-Cvar J; Crevenna R; Heinz G
    Wien Klin Wochenschr; 2021 Feb; 133(3-4):86-95. PubMed ID: 31932967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
    Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
    J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension.
    Kaiser R; Frantz C; Bals R; Wilkens H
    Respir Res; 2016 Jul; 17(1):96. PubMed ID: 27473366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.
    Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E
    Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potential diagnostic biomarkers for pulmonary hypertension.
    Tiede SL; Gall H; Dörr O; dos Santos Guilherme M; Troidl C; Liebetrau C; Voss S; Voswinckel R; Schermuly RT; Seeger W; Grimminger F; Zeiher AM; Dimmeler S; Möllmann H; Hamm CW; Ghofrani HA; Nef HM
    Eur Respir J; 2015 Nov; 46(5):1390-6. PubMed ID: 26250494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.